R. David Ebsworth - Nov 6, 2023 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Claire Poll, Attorney-in-fact for David R. Ebsworth
Stock symbol
VRNA
Transactions as of
Nov 6, 2023
Transactions value $
$316,080
Form type
4
Date filed
11/8/2023, 04:15 PM
Previous filing
Apr 28, 2023
Next filing
Apr 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Purchase $316K +160K +23.37% $1.98* 845K Nov 6, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Unless otherwise indicated, reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were purchased in multiple transactions at per share prices ranging from $1.9131 to $2.00, equivalent to $15.3050 to $16.00 per ADS. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
F3 Consists of (i) 844,640 Ordinary Shares represented by 105,580 ADSs; and (ii) 3 Ordinary Shares.